Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-113995
Filing Date
2024-11-04
Accepted
2024-11-04 19:38:30
Documents
2
Group Members
MARK ANGELOSC-SIGMA GLOBAL PARTNERS, LPYA GLOBAL INVESTMENTS II (U.S.), LPYAII GP II, LLCYAII GP, LPYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427411d2_sc13ga.htm SC 13G/A 114102
2 EXHIBIT 99.1 tm2427411d2_ex99-1.htm EX-99.1 11300
  Complete submission text file 0001104659-24-113995.txt   127546
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Subject) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92643 | Film No.: 241425214
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)